Digital twins began as static digital models used primarily for visualization and design. The review shows that they have ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reported completion of ...
Some requests by reviewers to cite their own publications are coercive and can unnecessarily delay indexation and publication.
Treating accessibility as a core product requirement, not a compliance checkbox, is a competitive advantage that most of your ...
AI design contest turns the future Forester into everything from a jungle tank to a rolling dessert, with fans now voting on ...
NeuroSense (NRSN) reported completion of the safety analysis from its proof-of-concept Phase 2, randomized, double-blind, placebo-controlled ...
Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...
The biggest source of teachers’ hesitation appears to be concerns about developmental appropriateness for young children.
Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...
Background Global warming poses a significant threat to human mental health, with disproportionate effects on vulnerable and ...
The approval of Emeprev will help veterinary professionals by providing an in-clinic antiemetic option.
On the policy front, the White House released an executive order 6 in February 2025 calling for the strengthening of price transparency initiatives in health care. In May 2025, the departments of HHS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback